Consumption of morphine can block the growth of blood vessel and tumour , according to a new research.

They found that chronic morphine use decreased levels of tumour angiogenesis in a manner dependent on the opioid receptor.
This effect was mediated by suppression of signalling induced by low oxygen concentrations, leading to a reduction in the levels of pro-angiogenic factors.
Therefore, morphine may not only serve as an analgesic for cancer patients, but may also inhibit tumour angiogenesis and growth.
Koodie et al conclude that "morphine is a potential inhibitor of tumor growth, through the suppression of tumor cell-induced angiogenesis and hypoxia-induced p38 MAPK activation of HIF-1. In addition to its analgesic potential, morphine can be exploited for its anti-angiogenic potential in cancer pain management; these findings support the use of morphine for cancer pain management."
The related report by Koodie et al, "Morphine suppresses tumour angiogenesis through a HIF1a/p38MAPK pathway," appears in the August 2010 issue of the American Journal of Pathology.
MEDINDIA




Email










